Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1976 Dec;52(614):770–781. doi: 10.1136/pgmj.52.614.770

The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease.

J D Fitzgerald
PMCID: PMC2496424  PMID: 13355

Abstract

The effect is critically reviewed of chronic administration of beta-adrenoreceptor antagonists on morbidity and mortality in angina pectoris and myocardial infarction. There is inconclusive evidence that the abrupt cessation of therapy with these agents may increase morbidity and mortality in angina pectoris. The type of anginal patient in which this may occur is not yet defined and neither is the mechanism. There is no evidence that beta-antagonists prolong the life of anginal patients. In the acute phase of experimental myocardial infarction, these drugs reduce mortality but do not do so in man. There is increasing evidence that they prolong life if administered to patients surviving the acute phase of myocardial infarction. The need for further studies is discussed.

Full text

PDF
770

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlmark G., Saetre H., Korsgren M. Letter: Reduction of sudden Deaths after myocardial infarction. Lancet. 1974 Dec 28;2(7896):1563–1563. doi: 10.1016/s0140-6736(74)90299-2. [DOI] [PubMed] [Google Scholar]
  2. Alderman E. L., Coltart D. J., Wettach G. E., Harrison D. C. Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med. 1974 Nov;81(5):625–627. doi: 10.7326/0003-4819-81-5-625. [DOI] [PubMed] [Google Scholar]
  3. Aronow W. S., Kaplan M. A. Propranolol combined with isosorbide dinitrate versus placebo in angina pectoris. N Engl J Med. 1969 Apr 17;280(16):847–850. doi: 10.1056/NEJM196904172801601. [DOI] [PubMed] [Google Scholar]
  4. Aronow W. S., Stemmer E. A. Bypass graft surgery versus medical therapy of angina pectoris. Am J Cardiol. 1974 Mar;33(3):415–420. doi: 10.1016/0002-9149(74)90325-7. [DOI] [PubMed] [Google Scholar]
  5. Barber J. M., Boyle D. M., Chaturvedi N. C., Singh N., Walsh M. J. Practolol in acute myocardial infarction. Acta Med Scand Suppl. 1976;587:213–219. doi: 10.1111/j.0954-6820.1976.tb05884.x. [DOI] [PubMed] [Google Scholar]
  6. DeQuattro V., Chan S. Raised plasma-catecholamines in some patients with primary hypertension. Lancet. 1972 Apr 15;1(7755):806–809. doi: 10.1016/s0140-6736(72)90796-9. [DOI] [PubMed] [Google Scholar]
  7. Fearon R. E. Propranolol in the prevention of ventricular fibrillation due to experimental coronary artery occlusion. Observations on its mode of action. Am J Cardiol. 1967 Aug;20(2):222–228. doi: 10.1016/0002-9149(67)90081-1. [DOI] [PubMed] [Google Scholar]
  8. Fox K. M., Chopra M. P., Portal R. W., Aber C. P. Long-term beta blockade: possible protection from myocardial infarction. Br Med J. 1975 Jan 18;1(5950):117–119. doi: 10.1136/bmj.1.5950.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GAZES P. C., RICHARDSON J. A., WOODS E. F. Plasma catechol amine concentrations in myocardial infarction and angina pectoris. Circulation. 1959 May;19(5):657–661. doi: 10.1161/01.cir.19.5.657. [DOI] [PubMed] [Google Scholar]
  10. Gifford R. H., Feinstein A. R. A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction. N Engl J Med. 1969 Feb 13;280(7):351–357. doi: 10.1056/NEJM196902132800703. [DOI] [PubMed] [Google Scholar]
  11. Griffiths J., Leung F. The sequential estimation of plasma catecholamines and whole blood histamine in myocardial infarction. Am Heart J. 1971 Aug;82(2):171–179. doi: 10.1016/0002-8703(71)90262-6. [DOI] [PubMed] [Google Scholar]
  12. Harris A. S., Otero H., Bocage A. J. The induction of arrhythmias by sympathetic activity before and after occlusion of a coronary artery in the canine heart. J Electrocardiol. 1971;4(1):34–43. doi: 10.1016/s0022-0736(71)80048-1. [DOI] [PubMed] [Google Scholar]
  13. Hope R. R., Williams D. O., el-Sherif N., Lazzara R., Scherlag B. J. The efficacy of antiarrhythmic agents during acute myocardial ischemia and the role of heart rate. Circulation. 1974 Sep;50(3):507–514. doi: 10.1161/01.cir.50.3.507. [DOI] [PubMed] [Google Scholar]
  14. Jéquier E., Perret C. Urinary excretion of catecholamines and their main metabolites after myocardial infarction; relationahip to the clinical syndrome. Eur J Clin Invest. 1970 Aug;1(2):77–83. doi: 10.1111/j.1365-2362.1970.tb00600.x. [DOI] [PubMed] [Google Scholar]
  15. Kaumann A. J., Aramendía P. Prevention of ventricular fibrillation induced by coronary ligation. J Pharmacol Exp Ther. 1968 Dec;164(2):326–332. [PubMed] [Google Scholar]
  16. Khan M. I., Hamilton J. T., Manning G. W. Early arrhythmias following experimental coronary occlusion in conscious dogs and their modification by beta-adrenoceptor blocking drugs. Am Heart J. 1973 Sep;86(3):347–358. doi: 10.1016/0002-8703(73)90044-6. [DOI] [PubMed] [Google Scholar]
  17. Khan M. I., Hamilton J. T., Manning G. W. Protective effect of beta adrenoceptor blockade in experimental coronary occlusion in conscious dogs. Am J Cardiol. 1972 Dec;30(8):832–837. doi: 10.1016/0002-9149(72)90007-0. [DOI] [PubMed] [Google Scholar]
  18. Lambert D. M. Beta-blockers and life expectancy in ischemic heart-disease. Lancet. 1972 Apr 8;1(7754):793–794. doi: 10.1016/s0140-6736(72)90547-8. [DOI] [PubMed] [Google Scholar]
  19. Maroko P. R., Braunwald E. Modification of myocardial infarction size after coronary occlusion. Ann Intern Med. 1973 Nov;79(5):720–733. doi: 10.7326/0003-4819-79-5-720. [DOI] [PubMed] [Google Scholar]
  20. Nellen M. Withdrawal of propranolol and myocardial infarction. Lancet. 1973 Mar 10;1(7802):558–558. doi: 10.1016/s0140-6736(73)90379-6. [DOI] [PubMed] [Google Scholar]
  21. Pentecost B. L., Austen W. G. Beta-adrenergic blockade in experimental myocardial infarction. Am Heart J. 1966 Dec;72(6):790–796. doi: 10.1016/0002-8703(66)90162-1. [DOI] [PubMed] [Google Scholar]
  22. RAAB W. The sympathogenic biochemical trigger mechanism of angina pectoris. Its therapeutic suppression and long-range prevention. Am J Cardiol. 1962 Apr;9:576–590. doi: 10.1016/0002-9149(62)90077-2. [DOI] [PubMed] [Google Scholar]
  23. Raftery E. B., Denman A. M. Systemic lupus erythematosus syndrome induced by practolol. Br Med J. 1973 May 26;2(5864):452–455. doi: 10.1136/bmj.2.5864.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Reimer K. A., Rasmussen M. M., Jennings R. B. Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs. Circ Res. 1973 Sep;33(3):353–363. doi: 10.1161/01.res.33.3.353. [DOI] [PubMed] [Google Scholar]
  25. Reynolds J. L., Whitlock R. M. Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset. Br Heart J. 1972 Mar;34(3):252–259. doi: 10.1136/hrt.34.3.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schaal S. F., Wallace A. G., Sealy W. C. Protective influence of cardiac denervation against arrhythmias of myocardial infarction. Cardiovasc Res. 1969 Jul;3(3):241–244. doi: 10.1093/cvr/3.3.241. [DOI] [PubMed] [Google Scholar]
  27. Slome R. Withdrawal of propranolol and myocardial infarction. Lancet. 1973 Jan 20;1(7795):156–156. doi: 10.1016/s0140-6736(73)90235-3. [DOI] [PubMed] [Google Scholar]
  28. Snow P. J. Effect of propranolol in myocardial infarction. Lancet. 1965 Sep 18;2(7412):551–553. doi: 10.1016/s0140-6736(65)90863-9. [DOI] [PubMed] [Google Scholar]
  29. Snow P. J. Treatment of acute myocardial infarction with propranolol. Am J Cardiol. 1966 Sep;18(3):458–462. doi: 10.1016/0002-9149(66)90070-1. [DOI] [PubMed] [Google Scholar]
  30. Sowton E. Beta-adrenergic blockade in cardiac infarction. Prog Cardiovasc Dis. 1968 May;10(6):561–572. doi: 10.1016/0033-0620(68)90006-6. [DOI] [PubMed] [Google Scholar]
  31. Valori C., Thomas M., Shillingford J. Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction. Am J Cardiol. 1967 Nov;20(5):605–617. doi: 10.1016/0002-9149(67)90001-x. [DOI] [PubMed] [Google Scholar]
  32. Wilhelmsson C., Vedin J. A., Wilhelmsen L., Tibblin G., Werkö L. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet. 1974 Nov 16;2(7890):1157–1160. doi: 10.1016/s0140-6736(74)90807-1. [DOI] [PubMed] [Google Scholar]
  33. Wilson D. F., Watson O. F., Peel J. S., Turner A. S. Trasicor in angina pectoris: a double-blind trial. Br Med J. 1969 Apr 19;2(5650):155–157. doi: 10.1136/bmj.2.5650.155. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES